1 |
Klag DN, Weaver DL, Alex JC. Surgical resection and radiolocalization of the sentinel node in breast cancer using gamma probe. Surg Oncol 1993;2:335-40
DOI
ScienceOn
|
2 |
Kataoka M, Kawamura M, Hamada K, Itoh H, Nishiyama T, Hamamoto K. Quantitative lymphoscintigraphy using 99m-Tc human serum albumin in patients with previously treated uterine cancer. Br J Radiol 1991;64:1119-21
DOI
ScienceOn
|
3 |
Campbel J, Bellen JC, Baker RJ, Cook DJ. Technetium-99m calcium phytate - optimization of calcium content for liver and spleen scintigraphy: concise communication. J Nucl Med 1981;22: 157-60
|
4 |
Eshima D, Fauconnier T, Eshima L, Thomback JR. Radiopharmaceuticals for lymphoscintigraphy: including dosimetry and radiation considerations. Semin Nucl Med 2000;30;25-32
DOI
ScienceOn
|
5 |
Kaplan WD, Davis MA, Rose CM. A comparison of two technetium-99m-labeled radiopharmaceuticals for lymphoscintigraphy: concise communication. J Nucl Med 1979;20:933-7
|
6 |
Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1997;39:456-66
DOI
ScienceOn
|
7 |
Alazraki NP, Eshima D, Eshima LA, Herda SC, Murray DR, Vansant JP, et al. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Semin Nucl Med 1997;27:55-67
DOI
ScienceOn
|
8 |
Watanabe T, Kimijima I, Ohtake T, Tsuchiya A, Shishido F, Takenoshita S. Sentinel node biopsy with technetium-99m colloidal rhenium sulphide in patients with breast cancer. Br J Surg 2001;88:704-7
DOI
ScienceOn
|
9 |
Krag D, Weaver D, Ashikaga T, Moffat F, Llimberg VS, Shiever C, et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 1998;339:941-6
DOI
ScienceOn
|
10 |
Strand SE, Persson BR. Quantitative lymphoscintigraphy I: Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. J Nucl Med 1997;20:1038-46
|
11 |
Subramanian G, McAfee JG, Mehta A, Blair RJ, Thomas ED. Tc-99m stannous phytate: a new in vivo colloid for imaging the reticuloendothelial system. J Nucl Med 1973;14:459
|
12 |
Tavares MGM, Sapienza MT, Galeb Jr NA, Belfort FA, Costa RR, Osorio CABT, et al. The use of Tc-99m phytate for sentinel node mapping in melanoma, breast cancer, and vulvar cancer: a study of 100 cases. Eur J Nucl Med 2001;28:1597-1604
DOI
ScienceOn
|
13 |
Veronesi U, Paganelli G, Viale G, Luini A, Zurride S, Galimberti V, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003;349:546-53
DOI
ScienceOn
|
14 |
Bennett LR, Lago G, Cutaneous lymphoscintigraphy in malignant melanoma. Semin Nucl Med 1983;13:61-9
DOI
ScienceOn
|
15 |
Alavi A, Staum MM, Shesol BF, Bloch PH. Technetium-99m Stannous phytate as an imaging agent for lymph node. J Nucl Med 1978;19:422-6
|
16 |
Pijper R, Meijer S, Hoekstra OS, Collet GJ, Comans EFL, Boom RPA, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997;38:366-8
|
17 |
Ege GN, Warbick A, Lymphoscintigraphy: a comparison of 99Tc(m) antimony sulphide colloid and 99mTc(m) stannous phytate. Br J Radiol 1979;52:124-9
DOI
ScienceOn
|
18 |
Sadek S, Owunwanne A. Abdel Dayem HM, Yacoub T. Preparation and evaluation of Tc-99m hydorxyethyl starch as a potential radiopharmaceutical for lymphoscintigraphy: comparison with Tc-99m human serum albumin, Tc-99m dextran, and Tc-99m sulfur microcolloid. Lymphology 1989;22:157-66
|
19 |
Wilher AJ, Mijinhout S, Franssen EJF. Radiopharmaceuticals in sentinel lymph-node detection. An overview. Eur J Nucl Med 1999;26 Suppl:36-42
DOI
|